HepSAY
hepatitis news and views from SA
Author James MorrisonPosted on Categories 2023 SpringLeave a comment on Stigma and Discrimination in a Post-Cure World – Part 2 In our last post we looked at how researchers at the Gender, Law and Drugs (GLaD) program at La Trobe University, Melbourne, have been running the Post-Cure Lives Project. This was designed to document the post-cure experiences of people successfully treated for hepatitis C,the views of key stakeholders,and latent and emerging discrimination-related challenges in a hepatitis C post-cure world.
Continue reading “Stigma and Discrimination in a Post-Cure World – Part 2”
Author James MorrisonPosted on Categories 2023 SpringLeave a comment on Stigma and Discrimination in a Post-Cure World – Part 1 Readers of this blog will know hepatitis C well as a blood-borne virus which can lead to cirrhosis, liver failure and other major health problems. Along with hepatitis B, it is the primary cause of liver cancer in Australia—the fastest growing cause of cancer death in the country.
Continue reading “Stigma and Discrimination in a Post-Cure World – Part 1”
Author James MorrisonPosted on Categories 2023 WinterLeave a comment on Hep C Treatment Barriers for Rural Aboriginal South Australians The rate of hepatitis C infections in Aboriginal and Torres Strait Islander communities in Australia is increasing even as infection rate decreases in the wider community. This is despite the introduction of direct-acting antiviral (DAA) drugs that offer the chance to completely eliminate the hepatitis C virus (HCV).
Continue reading “Hep C Treatment Barriers for Rural Aboriginal South Australians”
